These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19456252)

  • 1. Decreased intraocular pressure in mice following either pharmacological or genetic inhibition of ROCK.
    Whitlock NA; Harrison B; Mixon T; Yu XQ; Wilson A; Gerhardt B; Eberhart DE; Abuin A; Rice DS
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):187-94. PubMed ID: 19456252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of beta-blockers association with pilocarpine on rabbit intraocular pressure and heart rate.
    Drago F; Emmi I; Marino V
    Pharmacol Res; 1997 Apr; 35(4):299-302. PubMed ID: 9264045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an unfixed combination of latanoprost and pilocarpine on the intraocular pressure and pupil size of normal dogs.
    Sarchahi AA; Abbasi N; Gholipour MA
    Vet Ophthalmol; 2012 Mar; 15 Suppl 1():64-70. PubMed ID: 22050700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of topical administration of latanoprost, timolol, or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
    Smith LN; Miller PE; Felchle LM
    Am J Vet Res; 2010 Sep; 71(9):1055-61. PubMed ID: 20807145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure-Lowering Effects of Latanoprost.
    Roddy GW; Viker KB; Winkler NS; Bahler CK; Holman BH; Sheikh-Hamad D; Roy Chowdhury U; Stamer WD; Fautsch MP
    Invest Ophthalmol Vis Sci; 2017 May; 58(5):2715-2724. PubMed ID: 28538979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia.
    Van de Velde S; Van Bergen T; Sijnave D; Hollanders K; Castermans K; Defert O; Leysen D; Vandewalle E; Moons L; Stalmans I
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1006-16. PubMed ID: 24474276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys.
    Tokushige H; Inatani M; Nemoto S; Sakaki H; Katayama K; Uehata M; Tanihara H
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3216-22. PubMed ID: 17591891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
    Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of replacement of timolol-pilocarpine with latanoprost in pseudoexfoliation glaucoma.
    Bojić L; Mandić Z; Novak-Laus K; Sonicki Z; Karelović D
    Coll Antropol; 2003 Dec; 27(2):729-34. PubMed ID: 14746165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension.
    Kent AR; Vroman DT; Thomas TJ; Hebert RL; Crosson CE
    J Glaucoma; 1999 Aug; 8(4):257-62. PubMed ID: 10464735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M; Reis A; Sano ME; Susanna R
    J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, long-term, randomized study of the efficacy and safety of the drug combination pilocarpine 1% with clonidine 0.06% or clonidine 0.125% versus timolol 0.25%.
    Sihota R; Rajashekhar YL; Venkatesh P; Agarwal H
    J Ocul Pharmacol Ther; 2002 Dec; 18(6):499-506. PubMed ID: 12537676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
    Higginbotham EJ; Olander KW; Kim EE; Grunden JW; Kwok KK; Tressler CS;
    Arch Ophthalmol; 2010 Feb; 128(2):165-72. PubMed ID: 20142538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of timolol and latanoprost on respiratory and cardiovascular status in elderly patients with glaucoma.
    Ergin A; Ornek K; Güllü R; Bulcun E; Ekici M; Ekici A
    J Ocul Pharmacol Ther; 2009 Oct; 25(5):463-6. PubMed ID: 19552600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
    Ota T; Aihara M; Narumiya S; Araie M
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
    Ota T; Murata H; Sugimoto E; Aihara M; Araie M
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting intraocular pressure change before initiating therapy: timolol versus latanoprost.
    van der Valk R; Webers CA; Hendrikse F; de Vogel SC; Prins MH; Schouten JS
    Acta Ophthalmol; 2008 Jun; 86(4):415-8. PubMed ID: 18028236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.